Medvance Research Private Limited
About Medvance Research Private Limited
Data last updated:
Medvance Research Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24100MH2013PTC243392.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Munira Parvez Ali and Burhanuddin Ali Asger.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 355/4 Plot No 78 2nd Floor Agresen Square Central Avenue, Nagpur, Maharashtra, India – 440018.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.6 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹2,740 (net margin -1.7%) and EBITDA of -₹1,610 (EBITDA margin -1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medvance Research Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressH No 355/4 Plot No 78 2nd Floor Agresen Square Central Avenue, Nagpur, Maharashtra, India – 440018
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Medvance Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medvance Research Private Limited
FY 2025 filings availableMedvance Research Private Limited reported revenue of ₹1.6 Lakh (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 5% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,610 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,740 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medvance Research Private Limited, buy the company report.
Board of directors of Medvance Research Private Limited
Medvance Research has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munira Parvez Ali | Director | 16 May 2013 | 13 Years 5 Months | Current |
| Burhanuddin Ali Asger | Director | 16 May 2013 | 13 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Medvance Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medvance Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medvance Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medvance Research Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Burhanuddin Ali Asger was appointed as Director on 16 May 2013.
Frequently asked questions
Medvance Research is an active private limited company based in Nagpur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 May 2013 (13+ years old) and is registered under CIN U24100MH2013PTC243392.
Medvance Research has 2 current directors:
- Munira Parvez Ali - Director
- Burhanuddin Ali Asger - Director
The latest financial statements of Medvance Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Medvance Research is U24100MH2013PTC243392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medvance Research was incorporated on 16 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Nagpur.
Burhanuddin Ali Asger was appointed as Director on 16 May 2013. Munira Parvez Ali was appointed as Director on 16 May 2013.
The registered office of Medvance Research is at H No 3554 Plot No 78 2nd Floor Agresen Square Central Avenue, Nagpur, Maharashtra, India – 440018.
Medvance Research operates in the chemicals industry, in the manufacturing segment.
The compliance status of Medvance Research is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Medvance Research can be reached at its registered office: H No 3554 Plot No 78 2nd Floor Agresen Square Central Avenue, Nagpur, Maharashtra, India – 440018.